By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


FibroGen, Inc. 

225 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-866-7200 Fax: 650-866-7202



Company News
FibroGen, Inc. (FGEN) Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy 7/28/2015 7:05:31 AM
FibroGen, Inc. (FGEN) Announces Receipt Of $120 Million License Payment From AstraZeneca PLC (AZN) 6/30/2015 7:20:56 AM
FibroGen, Inc. (FGEN) To Webcast Presentation At The Goldman, Sachs & Co. Global Healthcare Conference 6/1/2015 5:03:45 PM
FibroGen, Inc. (FGEN) Announces First Quarter 2015 Financial Results 5/12/2015 11:24:34 AM
FibroGen, Inc. (FGEN) Announces Receipt Of Milestone Payment From AstraZeneca PLC (AZN) For Successful Completion Of Long-Term Pre-Clinical Safety Studies Of Roxadustat 5/7/2015 10:17:40 AM
FibroGen, Inc. (FGEN) Announces 2014 Financial Results And Provides Corporate Update 3/27/2015 9:42:33 AM
FibroGen, Inc. (FGEN) To Report Fourth Quarter And Full Year 2014 Financial Results On March 26, 2015 3/20/2015 9:33:21 AM
FibroGen, Inc. (FGEN) Announces Full Exercise Of Greenshoe Option 11/17/2014 4:23:51 PM
FibroGen, Inc. (FGEN) Announces Pricing Of Its IPO 11/14/2014 8:58:03 AM
SF's Billion Dollar Biotech FibroGen, Inc. Sets Terms For $124 Million IPO 10/31/2014 6:02:56 AM